Jessica Bechtel, NP
Acute Care · Troy, MINPI 1831853647
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 56 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Kerecis Limited accounts for 66.0% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2023 at $1,627 and has fallen 98.7% since, to $21 in 2025. Among acute care clinicians in MI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 56 payments — averaging $58.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Kerecis Limited$2K
- AbbVie$198
- Novartis$180
- Polynovo North America LLC$150
- Corium, LLC$148
- Lundbeck LLC$100
- plus $337 from 8 others
What the payments were for
- Food & beverage$3,278100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Kerecis Limited | 5 | $2,165 |
| AbbVie | 5 | $198 |
| Novartis | 21 | $180 |
| Polynovo North America LLC | 1 | $150 |
| Corium, LLC | 4 | $148 |
| Lundbeck LLC | 4 | $100 |
| Sumitomo Pharma America, Inc. | 4 | $67 |
| UCB, Inc. | 2 | $63 |
| Bristol Myers Squibb | 3 | $56 |
| AstraZeneca | 2 | $53 |
| Genentech USA, Inc. | 2 | $30 |
| Octapharma USA, Inc. | 1 | $24 |
| Lilly USA, LLC | 1 | $23 |
| Livanova USA, Inc. | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerecis Omega3 Marigen$4,962
- Kerecis Omega3 SurgiClose$4,533
- Kerecis Omega3 GraftGuide$1,329
- QULIPTA$125
- UBRELVY$125
- ADLARITY$115
How this compares
$3,278 in reported general payments places this provider in the 90th percentile of 567 acute care providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Rasagiline Mesylate | 13 | $2,605 |
| Donepezil Hcl | 43 | $1,202 |
| AmantadineAmantadine Hcl | 11 | $1,059 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 19 | $797 |
| Levetiracetam | 19 | $697 |
| Memantine Hcl | 12 | $190 |
| Gabapentin | 13 | $140 |
| Sumatriptan Succinate | 15 | $140 |
| Trazodone Hcl | 20 | $108 |
Paid to pharmacies, not to this prescriber.
Other acute care in Troy
- Laura CareyTroy$7K
- Janet WymanDetroit$103K
- Stephanie Mellon ReppenDetroit$57K
- Ashley WozniakLivonia$26K
- Julia BriggsBirch Run$16K
- Candise LovePort Huron$14K
- Janette GuertinPort Huron$14K
- Gregory AliNovi$13K
- Andrew PalmerLansing$9K
- Angela BrennanDearborn Heights$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.